Literature DB >> 15967412

Identification of N-arachidonylglycine, U18666A, and 4-androstene-3,17-dione as novel insulin Secretagogues.

Yukio Ikeda1, Haruhisa Iguchi, Masanori Nakata, Ryoichi X Ioka, Toshiya Tanaka, Satoshi Iwasaki, Kenta Magoori, Shinobu Takayasu, Tokuo T Yamamoto, Tatsuhiko Kodama, Toshihiko Yada, Takeshi Sakurai, Masashi Yanagisawa, Juro Sakai.   

Abstract

The glucose-induced insulin secretion is fine-tuned by numerous factors. To systematically identify insulinotropic factors, we optimized a primary beta-cell-based functional assay to monitor intracellular Ca2+ flux ([Ca2+]i). By this assay system, we successfully identified several insulinotropic peptides including cholecystokinin, gastrin releasing peptide, vasopressin, and oxytocin from tissue extracts. Screening of an assortment of chemical compounds, we determined three novel insulin secretagogues: N-arachidonylglycine (NAGly), 3beta-(2-diethylamino-ethoxy) androstenone hydrochloride (U18666A), and 4-androstene-3,17-dione. The NAGly increased [Ca2+]i through stimulation of the voltage-dependent Ca2+ channels and it was dependent on extracellular glucose level. On the other hand, U18666A and 4-androstene-3,17-dione increased [Ca2+]i in the presence of K ATP channel opener diazoxide while it was inhibited by the presence of Ca2+ channel blocker nitrendipine, suggesting that their effects are independent of K ATP channel. These unique features will be useful for further development of insulinotropic factors and drugs for treating type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967412     DOI: 10.1016/j.bbrc.2005.06.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development.

Authors:  Hee-Yong Kim; Arthur A Spector; Zheng-Mei Xiong
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-23       Impact factor: 3.072

2.  In vivo evidence that N-oleoylglycine acts independently of its conversion to oleamide.

Authors:  Shalini Chaturvedi; William J Driscoll; Brenda M Elliot; Martha M Faraday; Neil E Grunberg; Gregory P Mueller
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-10-05       Impact factor: 3.072

3.  Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration.

Authors:  M Okamoto; M Ohara-Imaizumi; N Kubota; S Hashimoto; K Eto; T Kanno; T Kubota; M Wakui; R Nagai; M Noda; S Nagamatsu; T Kadowaki
Journal:  Diabetologia       Date:  2008-03-28       Impact factor: 10.122

Review 4.  Orphan endogenous lipids and orphan GPCRs: a good match.

Authors:  Heather B Bradshaw; Sung Ha Lee; Douglas McHugh
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-18       Impact factor: 3.072

Review 5.  The cannabinoid acids, analogs and endogenous counterparts.

Authors:  Sumner H Burstein
Journal:  Bioorg Med Chem       Date:  2014-04-01       Impact factor: 3.641

Review 6.  The elmiric acids: biologically active anandamide analogs.

Authors:  Sumner Burstein
Journal:  Neuropharmacology       Date:  2007-11-23       Impact factor: 5.250

7.  Ablation of PM20D1 reveals N-acyl amino acid control of metabolism and nociception.

Authors:  Jonathan Z Long; Alexander M Roche; Charles A Berdan; Sharon M Louie; Amanda J Roberts; Katrin J Svensson; Florence Y Dou; Leslie A Bateman; Amir I Mina; Zhaoming Deng; Mark P Jedrychowski; Hua Lin; Theodore M Kamenecka; John M Asara; Patrick R Griffin; Alexander S Banks; Daniel K Nomura; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

8.  The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.

Authors:  Heather B Bradshaw; Neta Rimmerman; Sherry Shu-Jung Hu; Valery M Benton; Jordyn M Stuart; Kim Masuda; Benjamin F Cravatt; David K O'Dell; J Michael Walker
Journal:  BMC Biochem       Date:  2009-05-21       Impact factor: 4.059

9.  Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating.

Authors:  Magdalena Kotańska; Kamil Mika; Małgorzata Szafarz; Monika Kubacka; Christa E Müller; Jacek Sapa; Katarzyna Kieć-Kononowicz
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.